HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator - Test2 - elhamkhani - TriplyDB

HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator

HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator

http://www.wikidata.org/entity/Q24569559

about

The Vpr protein from HIV-1: distinct roles along the viral life cycle Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation.Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development Visualizing Vpr-induced G2 arrest and apoptosis Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha Synthesis of a Vpr-Binding Derivative for Use as a Novel HIV-1 Inhibitor Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level Human immunodeficiency virus type 1 Vpu and cellular TASK proteins suppress transcription of unintegrated HIV-1 DNA.Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest.Fluorescent protein-tagged Vpr dissociates from HIV-1 core after viral fusion and rapidly enters the cell nucleus.Pathogenesis of HIV-1 infection within bone marrow cells.Cell-type-specific proteome and interactome: using HIV-1 Tat as a test case.HIV-1 Vpr stimulates NF-κB and AP-1 signaling by activating TAK1.Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression Genetic variation and HIV-associated neurologic disease.A conserved dileucine-containing motif in p6(gag) governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV(mac) and SIV(agm)Vpr-host interactions during HIV-1 viral life cycle.Protein kinase A phosphorylation activates Vpr-induced cell cycle arrest during human immunodeficiency virus type 1 infection.Exposed hydrophobic residues in human immunodeficiency virus type 1 Vpr helix-1 are important for cell cycle arrest and cell death Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex.Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates.Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products.Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators.The HIV1 protein Vpr acts to promote G2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP/DCAF1 as an adaptor.Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA.HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention SET7/9-dependent methylation of ARTD1 at K508 stimulates poly-ADP-ribose formation after oxidative stress.HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition Epigenetic displacement of HP1 from heterochromatin by HIV-1 Vpr causes premature sister chromatid separation.HIV-1 Vpr induces interferon-stimulated genes in human monocyte-derived macrophages.Differential regulation of NF-κB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins.The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor.Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells HIV Vpr protein upregulates microRNA-122 expression and stimulates hepatitis C virus replication Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis.The human immunodeficiency virus type 1 Vpr protein and its carboxy-terminally truncated form induce apoptosis in tumor cells.An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.

P2860

Q21245211-37707A90-A612-46B5-86FC-72F3D5B37418 Q24530134-058E66BB-EC25-42F1-8B06-1DB6C38F859D Q24537547-EF7A0A83-2A6B-446B-BF78-778C8E5D4FB9 Q24537650-91971B51-745E-40D0-8E77-21BD871CCEB0 Q27329545-F1222075-7C5E-4F37-BFE3-AA67CD50D100 Q28117643-44AB4426-7179-441F-9405-B1CD58903019 Q28551700-7DDEBE3F-CE17-444D-A5B7-0F54524A43AE Q28580101-8A3D09DE-F9E0-4CFA-9139-9D5F4D7723B7 Q30422793-CF47D1BF-F1D6-4A5D-8315-73C8C0182804 Q30656125-293F4D2D-D44A-45EE-96A1-255AC7D3F12E Q30671100-7F419EFD-FFEB-4678-9BCF-B82E619EE4B1 Q33334766-9A4A568E-7639-4DEA-9EE1-A805DA9057CE Q33347964-E664FD7C-77F3-44F0-946E-3AECF587A583 Q33756614-F22E6812-D774-440C-A734-9298A65184D3 Q33787316-DA49E005-C0F3-48ED-9B15-AEC3FF9A0DAD Q33804558-9B2157A9-059A-4EB6-BC1E-EAA89BAE7B30 Q33819189-4922AF1F-DE7E-4518-9B1C-75DB370F34E7 Q33824939-410C070D-18BA-4319-A4B0-10868E636309 Q33828332-8BF825A5-8D01-48C2-BAC3-28A28685FA7B Q33990739-E5F5633F-7D0F-43A7-AE64-F74BDF0469CF Q34031619-6F4BBBD4-7931-4177-BB62-26D826EBB31D Q34101377-0DDDD7BA-E58B-487E-A126-23D9CCA920EE Q34220186-9E66E977-B1E7-443D-96B1-A3307E86B3B7 Q34291542-1CDFE724-71DE-4B74-8162-0F63AF5171AB Q34347794-203871C8-BBAD-4B1D-BE4D-A841A16D425C Q34647751-DFF86B77-8E1C-45E4-81B9-4C9870F93D6B Q34782531-66D31E28-C816-4ED2-887E-DF02E7678607 Q34957142-932EBD4F-1FEE-4364-A28E-8CD8406813D4 Q35006936-DB8F0B04-168F-4C7C-A6CF-B0542C4A5972 Q35009720-9C3CE9E1-64DE-453A-AFBD-F0CC3D847991 Q35020718-92D33FB4-66E7-4006-A591-0E9064ECD387 Q35208457-1DF39A25-94BD-42A7-8241-B0B0051EF8E7 Q35234824-41F4ECFB-B43B-4059-B351-8CE7D0573FE2 Q35549043-788FF2ED-0D76-4420-A9DD-39F265DD7302 Q35834594-B32FC03F-61BC-491F-AEAC-5C3FE6095F4B Q35948038-D056AFBD-884B-4F45-9111-179FE1189972 Q36376632-59663072-9281-43A8-9B23-F6967BDE0EFA Q37063467-6C52B1C5-2841-4F64-9906-0E1FCFEDD1CA Q37327926-7C4F37C5-19AF-4FEC-98BD-7CBED245B8CE Q37336473-1F60BD5C-01AC-48F7-8447-181DBC4EBC0C

P2860

HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator

http://www.wikidata.org/entity/Q24569559

description

1998 nî lūn-bûn

@nan

1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

HIV transcriptional activation ...... iated by the p300 co-activator

@ast

HIV transcriptional activation ...... iated by the p300 co-activator

@en

HIV transcriptional activation ...... iated by the p300 co-activator

@nl

type

label

HIV transcriptional activation ...... iated by the p300 co-activator

@ast

HIV transcriptional activation ...... iated by the p300 co-activator

@en

HIV transcriptional activation ...... iated by the p300 co-activator

@nl

prefLabel

HIV transcriptional activation ...... iated by the p300 co-activator

@ast

HIV transcriptional activation ...... iated by the p300 co-activator

@en

HIV transcriptional activation ...... iated by the p300 co-activator

@nl

P1433

Q24569559-73D0C2F8-1B6A-4DFB-8F56-31578EBCAE46

P1476

Q24569559-68263517-C3CB-4A3F-A24F-024CFB295544

P2093

Q24569559-461031E4-DC44-4EC0-B143-E5A3F247C1D7

Q24569559-76CFA166-FFEA-4190-8D97-2988E1510D08

Q24569559-CD58BAB9-5279-471A-BADE-A1B85FE84131

Q24569559-F7C6AC98-F8DB-44B0-9BD9-78B042BA8628

Q24569559-FB6FD5F6-11A8-4D86-9014-60F82BE18A24

P2860

Q24569559-02557FFA-9B3B-4CBA-8C4F-17DDFF9782A2

Q24569559-079720BF-CDD2-47B8-95D1-B610CE66FF2B

Q24569559-0D468D93-9E63-43A5-9263-3C29A5AC5167

Q24569559-0E71A6D0-0443-4886-9ACF-1BCAE585B270

Q24569559-0F405AC2-479C-463A-95B4-EDD799528BA1

Q24569559-1BE14E3A-DF33-4A41-B061-F39BFDB2C485

Q24569559-21AA81F1-B84B-4B6D-B6CD-511A205BBD99

Q24569559-2234D338-E64D-42DF-9AA5-C3047B35CA21

Q24569559-3072F30E-6B2F-46DC-B3A9-C5D4BCDF064C

Q24569559-3616179D-51A6-4D20-9E4C-D57735A5C454

P304

Q24569559-29FBAB75-2EC0-4355-BE9F-8A3290A6A6F4

P31

Q24569559-305327F4-0794-4EB8-8EAE-B50F615650EB

P356

Q24569559-984C59D6-F980-40D6-849B-4F08F3AC5A91

P407

Q24569559-CE953070-1AF4-4FE5-8710-2717FFAD99BE

P433

Q24569559-E02F3CAC-DACD-46DD-B5BD-7F0041045315

P478

Q24569559-87009C84-3042-425B-8D2A-F6779B8EB6B8

P50

Q24569559-9855A05E-EC43-48EB-A1CD-83D7891042A3

P577

Q24569559-34A7F428-C456-4355-AB5A-496AE695C0AB

P5875

Q24569559-43601674-253B-429F-9E84-A67EF7D7EE90

P698

Q24569559-FD1B1AB3-62CA-44F9-A96C-B14FD609BD17

P932

Q24569559-9044AF2D-04EB-46D5-93FF-C7F37C507A0C

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

HIV transcriptional activation ...... iated by the p300 co-activator

@en

P2093

C Woffendin

http://www.w3.org/2001/XMLSchema#string

E A Cohen

http://www.w3.org/2001/XMLSchema#string

G J Nabel

http://www.w3.org/2001/XMLSchema#string

L K Felzien

http://www.w3.org/2001/XMLSchema#string

R A Subbramanian

http://www.w3.org/2001/XMLSchema#string

P2860

Synergistic activation of transcription by CBP and p53

Binding and modulation of p53 by p300/CBP coactivators

Nuclear protein CBP is a coactivator for the transcription factor CREB

Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3)

Human p300 protein is a coactivator for the transcription factor MyoD

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells

Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import

Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr

Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B

Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity

P304

5281-5286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.95.9.5281

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Michael O Hottiger

P577

1998-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13720702

http://www.w3.org/2001/XMLSchema#string

P698

9560267

http://www.w3.org/2001/XMLSchema#string

P932

20252

http://www.w3.org/2001/XMLSchema#string